Tc-99m-annexin V-128

N/A

Report date: 2025/11/24 11:49:23

Base Information

Drug NameTc-99m-annexin V-128
Drug Alias NameTc-99m-rhAnnexin-V-12899mTechnetium-labelled rhAnnexin V-128Tc-99m-recombinant human annexin V-128
ClassificationBiologics > Protein drugs > Recombinant proteinRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Technetium > 99mTc +[4] 
Mechanisms of ActionPhosphatidylserine agonistsDiagnostic imaging enhancersSingle-photon emission-computed tomography enhancers
TargetsPhosphatidylserine
Therapy Area/IndicationsAcute Lung InjuryPulmonary Disease, Chronic ObstructiveArthritis, Rheumatoid +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAaa Usa IncAtreus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Accelerator Applications SaColumbia University
Active IndicationsN/A
Inactive IndicationsAcute Lung InjuryPulmonary Disease, Chronic ObstructiveArthritis, Rheumatoid +[5] 

Other Information

ATC CodeN/A
Related LinksN/A